|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.115 EUR | -0.45% |
|
-5.11% | -24.15% |
| 07/07 | Laboratorio Erfo continues buyback, acquires 15,000 treasury shares | AN |
| 29/06 | Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares | AN |
Business description: Laboratorio Farmaceutico Erfo S.p.A.

Number of employees: 50
Sales by Activity: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
Network | - | 3.95M | 4.74M | 4.62M | 7.86M |
Direct | 598K | 500K | 703K | 850K | 1.09M |
Other | - | 457K | 576K | 562K | 672K |
Medical | - | 125K | 244K | 306K | 411K |
Revenues from Services | 1.12K | - | - | - | - |
Wholesale Sales Revenues | 4.07M | - | - | - | - |
Geographical breakdown of sales: Laboratorio Farmaceutico Erfo S.p.A.
| Fiscal Period: December | 2021 (EUR) | 2022 (EUR) | 2023 (EUR) | 2024 (EUR) | 2025 (EUR) |
|---|---|---|---|---|---|
ITALY | 4.66M | 5.01M | 5.23M | 5.33M | 8.96M |
France | - | - | 797K | 852K | 898K |
Belgium | - | - | 228K | 157K | 176K |
Other (EU) | - | - | 5K | - | - |
Spain | 8K | 15.4K | 5.17K | 184 | - |
Executive Committee: Laboratorio Farmaceutico Erfo S.p.A.
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CEO | Chief Executive Officer | 56 | 01/01/2013 |
| Director of Finance/CFO | - | - |
Composition of the Board of Directors: Laboratorio Farmaceutico Erfo S.p.A.
| Director | Title | Age | Since |
|---|---|---|---|
Alessandro Cutè
CHM | Chairman | 56 | 01/01/2013 |
Flavio Corpina
BRD | Director/Board Member | 47 | 01/01/2017 |
Fabio Giuffre
BRD | Director/Board Member | 45 | - |
Company details: Laboratorio Farmaceutico Erfo S.p.A.
Laboratorio Farmaceutico Erfo SpA
Viale Geki Russo, 9
98049, Tirrena
+39 09 09 14 61 25
http://www.erfo.it
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.45% | -5.11% | -9.35% | +8.78% | 11.03M | ||
| -0.52% | +3.21% | +89.52% | +125.32% | 1,057B | ||
| +0.88% | +1.13% | +49.56% | +49.79% | 625B | ||
| +0.89% | -1.95% | +24.23% | +63.19% | 435B | ||
| +1.02% | +4.44% | +50.95% | +39.30% | 363B | ||
| +0.32% | +1.57% | +31.70% | +39.61% | 296B | ||
| +0.05% | +3.76% | +8.12% | +6.90% | 249B | ||
| +1.51% | +6.69% | +42.58% | +58.47% | 222B | ||
| -0.34% | +0.89% | -5.46% | -51.12% | 209B | ||
| +1.80% | +2.30% | +11.56% | +66.16% | 165B | ||
| Average | -0.09% | +0.67% | +29.34% | +40.64% | 362.08B | |
| Weighted average by Cap. | +0.09% | +1.33% | +48.68% | +64.08% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ERFO Stock
- Company Laboratorio Farmaceutico Erfo S.p.A.
Select your edition
All financial news and data tailored to specific country editions

















